MedPage Today on MSN
For Your Patients: What to Know About the Newest Treatments for HR+/HER2- Breast Cancer
Resistance to initial therapy sets the stage for many other options ...
That’s the big idea behind Zymosense, “The Nanoassay Company,” a startup that’s spinning off technology developed in the lab ...
News Medical on MSN
Researchers discover the enzyme responsible for chromothripsis in cancer
University of California San Diego researchers have discovered the enzyme responsible for chromothripsis, a process in which a single chromosome is shattered into pieces and rearranged in a scrambled ...
Scott Nelson, left, and Nathaniel Kallmyer work in the laboratory of Zymosense, a startup company based in the Iowa State ...
Metabolic dysfunction-associated steatotic liver disease (MASLD), a spectrum of liver conditions ranging from simple ...
Discover why Eli Lilly and Company's retatrutide weight loss breakthrough positions LLY as a leader in obesity therapeutics.
Fermenta Biotech Limited (BSE: 506414) (Bloomberg: FERMENTA.IN) (Reuters: FERM.BO), India's leading manufacturer of ...
University of California San Diego researchers have discovered the enzyme responsible for chromothripsis, a process in which ...
MedPage Today on MSN
The Latest on Emerging Therapies for Metastatic HR+/HER2- Breast Cancer
Novel weapons to counter endocrine therapy resistance and treat progressive disease ...
Magnesium and potassium are important minerals for health, and many people don't get enough of either. Taking both with food can improve absorption.
From bitter hop bombs to hazy juice, today’s IPA family turns a 250-year-old export beer into America’s favorite style.
Testing for aldosterone levels may hold the key to treatment-resistant hypertension and many other cardiac conditions, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results